M
Marker Therapeutics, Inc. (MRKR)
NCM – Real Time Price. Currency in USD
1.31
+0.01 (0.38%)
At close: Jun 26, 2026, 4:00 PM EDT
1.32
+0.00 (0.38%)
After-hours: Jun 26, 2026, 4:49 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
1.31
+0.01 (0.38%)
At close: Jun 26, 2026, 4:00 PM EDT
1.32
+0.00 (0.38%)
After-hours: Jun 26, 2026, 4:49 PM EDT
No Data
There are no news for this stock.
Cash reserves $15.6M barely cover the upcoming debt maturities $0.0
Total current assets $17.4M exceed Total current liabilities $3.6M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is near the industry average, reflecting balanced leverage
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$1.4M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 4.79 | 6.05 | 10 | |
| Quick ratio | 4.79 | 5.63 | 10 | |
| Debt to Equity | 0.00 | 0.30 | 10 | |
| Debt to Assets | 0.00 | 1.04 | 10 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 8.2 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 4M | 3M | 7M | 4M | 3M |
| Gross Profit | 5M | N/A | N/A | N/A | N/A |
| Operating Income | -20M | -15M | -11M | -12M | -12M |
| Net Income | -30M | -17M | -11M | -12M | -11M |
| EBITDA | -20M | -15M | -11M | -12M | -12M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | -22.54 | 13.2 | 4.5 |
| Next quarter | -44.68 | -125 | 1.0 |
| Current year | -20.2 | -21.94 | 1.0 |
| Next year | 609.69 | -5.19 | 5.5 |
| Weighted average score | 3.0 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -99.99 | -86.65 | -59.99 | 26.1 | 3.3 |
| Y/Y | 999 | 28.49 | 60 | 74.47 | 10 |
| 3y average | 15.71 | 22.24 | 26.92 | 20.86 | 9.8 |
| 5y average | 79.22 | 9.88 | 25.1 | 14.01 | 8.5 |
| Weighted average score | 7.9 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |